ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

IKT Inhibikase Therapeutics Inc

1.39
0.05 (3.73%)
2024年5月4日 - 終了
15分遅延
名称 銘柄コード 市場 種別
Inhibikase Therapeutics Inc IKT NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
0.05 3.73% 1.39 13:00:10
始値 安値 高値 終値 前日終値
1.38 1.3304 1.51 1.39 1.34
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/4/1905:30GLOBEInhibikase Therapeutics Issues Letter to Shareholders and..
2024/4/0321:05GLOBEInhibikase Therapeutics Announces Pre-IND Meeting with the..
2024/3/2805:15GLOBEInhibikase Therapeutics Reports Fourth Quarter and Full Year..
2024/3/0722:30GLOBEInhibikase Therapeutics to Provide Trial Update for..
2024/2/2906:05GLOBEInhibikase Therapeutics Announces Full Outcomes of its..
2024/2/0721:59EDGAR2Form 8-K - Current report
2024/2/0721:55GLOBEInhibikase Therapeutics Announces Preliminary Outcomes of..
2024/2/0206:49EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2024/2/0206:09EDGAR2Form 8-K - Current report
2024/1/2923:05GLOBEInhibikase Therapeutics Announces Publication Highlighting..
2024/1/1706:31EDGAR2Form 8-K - Current report
2024/1/1706:05GLOBEInhibikase Therapeutics Announces Planned Retirement of..
2023/12/1922:30GLOBEInhibikase Therapeutics Issues Letter to Shareholders and..
2023/12/0422:35GLOBEInhibikase Therapeutics Granted Pre-NDA Meeting with the FDA..
2023/11/1506:30GLOBEInhibikase Therapeutics Reports Third Quarter Financial..
2023/11/0723:28GLOBECorrecting & Replacing -- Inhibikase Therapeutics to Report..
2023/11/0722:00GLOBEInhibikase Therapeutics to Report Second Quarter Financial..
2023/10/1706:24EDGAR2Form 10-K/A - Annual report [Section 13 and 15(d), not S-K..
2023/10/1620:00GLOBEInhibikase Therapeutics Highlights Unblinded Functional..
2023/10/0421:30GLOBEInhibikase Therapeutics Receives FDA Orphan Drug Designation..
2023/9/2100:23EDGAR2Form 8-K - Current report
2023/8/2421:30PRNUSInhibikase Therapeutics Announces Development of Novel..
2023/8/2221:05PRNUSInhibikase Therapeutics to Present at the International..
2023/8/2121:30PRNUSInhibikase Therapeutics Initiates Development of Second..
2023/8/1721:30PRNUSInhibikase Therapeutics Announces Completion of the 501..
2023/8/1505:20PRNUSInhibikase Therapeutics Reports Second Quarter Financial..
2023/8/1505:07EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/8/0721:05PRNUSInhibikase Therapeutics to Report Second Quarter Financial..
2023/7/1806:29EDGAR2Form 8-K - Current report
2023/7/1805:05PRNUSInhibikase Therapeutics Regains Compliance with Nasdaq..
2023/7/0610:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/7/0610:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/6/3001:15EDGAR2Form 8-K - Current report
2023/6/2922:29PRNUSInhibikase Therapeutics Announces a 1-for-6 Reverse Stock..
2023/6/2221:05PRNUSInhibikase Therapeutics Announces Selection of the..
2023/6/2121:05PRNUSInhibikase Therapeutics Initiates Medical and Patient..
2023/5/3021:05PRNUSInhibikase Therapeutics to Present at the LD Micro..
2023/5/1620:45PRNUSInhibikase Therapeutics Announces Dosing of First Patient in..
2023/5/1521:30PRNUSInhibikase Therapeutics Reports First Quarter Financial..
2023/5/0821:05PRNUSInhibikase Therapeutics to Report First Quarter Financial..

最近閲覧した銘柄

Delayed Upgrade Clock